| http://www.w3.org/ns/prov#value | - It has been obvious for years that breast cancer is a heterogeneous disease, and more recently it has become apparent that dissection of the molecular basis of malignancies classifies tumours into increasingly large numbers of subtypes that require individualized treatment.The advent of genomics and proteomics could be regarded as a natural progression from the use of only a few markers to the com
|
